ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SNY announcements Sanofi announcements and dividends declared USA

Sanofi Complete list of announcements declared & dividend announcements by Sanofi SNY

Sanofi SNY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Sanofi SNY

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple sclerosis.
Announcement as on 25 March 2025

Sanofi launches Rezurock against chronic Graft-versus-host disease in India
Sanofi Healthcare India has obtained marketing authorization for Rezurock, a drug for treating Chronic graft versus host disease (cGVHD), a condition that occurs after allogeneic stem cell transplants. The drug, approved by USFDA and CDSCO, offers a new tr
Announcement as on 10 February 2025

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?
Sanofi (SNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Announcement as on 18 December 2024

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength?
Sanofi (SNY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Announcement as on 18 December 2024

CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare India
Global investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. This follows exclusive negotiations to acquire a controlling stake in Opella. The offer price is Rs 4,982.05 per sh
Announcement as on 21 October 2024

Announcements by Sanofi first page | Next page | Prev page |

SNY Sanofi current price & indicator signals

Moving Averages for Sanofi

  • 5Day Average: 44.08
  • 12Day Average: 43.89
  • 20Day Average: 43.74
  • 50Day Average: 43.49
  • 100Day Average: 44.5
  • 150Day Average: 45.42
  • 200Day Average: 46.49

SNY Indicators & signals

Indicator MACD (12,26,9)

43.77, 43.63, 0.18
Indicator MACD is in positive zone

Indicator ADX (14)

15.63, 24.77, 33.94
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SNY Sanofi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
31 Fri Jul 2026 43.08 42.48 to 43.10 0.44% 0.75 times
30 Thu Jul 2026 42.89 41.42 to 42.93 -4.43% 2.61 times
29 Wed Jul 2026 44.88 44.79 to 45.67 -1.45% 0.74 times
28 Tue Jul 2026 45.54 44.89 to 45.65 3.5% 0.73 times
27 Mon Jul 2026 44.00 43.51 to 44.49 1.5% 0.76 times
24 Fri Jul 2026 43.35 42.94 to 43.49 0% 0.78 times
24 Fri Jul 2026 43.35 42.94 to 43.49 -0.02% 0.78 times
23 Thu Jul 2026 43.36 42.88 to 43.51 -0.98% 0.49 times
22 Wed Jul 2026 43.79 43.79 to 44.72 0.09% 0.72 times
21 Tue Jul 2026 43.75 43.55 to 44.19 -0.52% 0.56 times
20 Mon Jul 2026 43.98 43.76 to 44.22 -1.52% 1.82 times
17 Fri Jul 2026 44.66 43.88 to 44.85 1.02% 0.94 times

Videos related to: SNY announcements Sanofi announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

SNY announcements Sanofi announcements and dividends declared USA

 

Back to top